Subchapter A

General Administrative Provisions

• SEC. 701. [21 USC §371] Regulations and Hearings 
• SEC. 702. [21 USC §372] Examinations and Investigations 
• SEC. 703. [21 USC §373] Records of Interstate Shipment 
• SEC. 704. [21 USC §374] Factory Inspection 
• SEC. 705. [21 USC §375] Publicity 
• SEC. 706. [21 USC §376] Seafood Inspection 
• SEC. 707. [21 USC §378] Advertising of Certain Foods 
• SEC. 708. [21 USC §379] Confidential Information 
• SEC. 709. [21 USC §379a] Presumption 
• SEC. 710. [21 USC §379b] Consolidated Administrative and Laboratory Facility 
• SEC. 711. [21 USC §379d] Automation of Food and Drug Administration 
• SEC. 712. [21 USC §379d-1] Conflicts of Interest  
• SEC. 713. [21 USC §379d-2] Policy on the Review and Clearance of Scientific Articles Published by FDA Employees 

Subchapter B

Colors

• SEC. 721. [21 USC §379e] Listing and Certification of Color Additives for Foods, Drugs, and Cosmetics 

Subchapter C

Fees

• SEC. 731. [21 USC 379f] Recovery and Retention of Fees for Freedom of Information Requests 
• SEC. 735. [21 USC §379g] Definitions 
• SEC. 736. [21 USC §379h] Authority to Assess and Use Drug Fees 
• SEC. 736A. [21 USC §379h–1] Fees Relating to Advisory Review of Prescription-Drug Television Advertising 
• SEC. 736B. [21 USC §379h–2] Reauthorization; Reporting Requirements 
• SEC. 737. [21 USC §379i] Definitions 
• SEC. 738. [21 USC §379j] Authority to Assess and Use Device Fees 
• SEC. 738A. [21 USC §379j–1] Reauthorization; Reporting Requirements 
• SEC. 739. [21 USC §379j–11] Definitions 
• SEC. 740. [21 USC §379j–12] Authority to Assess and Use Animal Drug Fees. 

Subchapter D

Information and Education

• SEC. 741. [21 USC §379k] Information System 
• SEC. 742. [21 USC §379l] Education 

Subchapter E

Environmental Impact Review

• SEC. 746. [21 USC §379o] Environmental Impact 

Subchapter F

National Uniformity for Nonprescription Drugs and Preemption for Labeling or Packaging of Cosmetics

• SEC. 751. [21 USC §379r] National Uniformity for Nonprescription Drugs 
• SEC. 752. [21 USC §379s] Preemption for Labeling or Packaging of Cosmetics 

Subchapter G

Safety Reports

• SEC. 756. [21 USC §379v] Safety Report Disclaimers 
• SEC. 760. [21 USC §379aa] Serious Adverse Event Reporting for Nonprescription Drugs 
• SEC. 761. [21 USC §379aa–1] Serious Adverse Event Reporting for Dietary Supplements 

Subchapter I

Reagan-Udall Foundation for the Food and Drug Administration

• SEC. 770. [21 USC §379dd] Establishment and Functions of the Foundation 
• SEC. 771. [21 USC §379dd–1] Location of Foundation 

• SEC. 772. [21 USC §379dd–2] Activities of the Food and Drug Administration